Andrew Young

Company: I2O Therapeutics

Job title: Chief Scientific & Medical Officer

Seminars:

Roundtable: Early Considerations for Manufacturing GLP-1s to Streamline Processes & Reduce Delays 8:30 am - 9:30 am

Ensuring the build of a resilient supply chain to minimize disruption and ensure on time delivery of GLP-1s to patients Discussing the importance of process optimization in reducing cost of goods and scaling up GLP-1 manufacturing processes Identifying and mitigating potential risks throughout the manufacturing and distribution process ahead of time to overcome challenges pre-emptively Read more

day: Day Two